Menu
About Us
About Imunexus Therapeutics
Board of Directors
Executive Team
Our Philosophy
Technology
Technology Approach
Lead Product Candidates
News & Events
Company News
Conferences
Investors
Why Invest
Investor News
Corporate Governance
Email Alerts
Contact
Partnerships
Contact Us
News
Recent Posts
Imunexus R&D activities relocated to the La Trobe Institute for Molecular Science
Recommencement of Operations
Successful Capital Raise
Archives
July 2021
April 2021
March 2021
March 21st, 2021
Successful Capital Raise
Read More
1